- JP-listed companies
- Techno Medica Co., Ltd.
- Income statement
Techno Medica Co., Ltd. (6678) Income statement
Market cap
¥18.4B
P/E ratio
18.8x
Technomedica develops and manufactures clinical laboratory analyzers and medical devices for hospitals and medical facilities worldwide, specializing in automated blood testing systems.
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | 2026/03 | |
| Revenue | 7,694 | 8,143 | 8,934 | 9,145 | 9,032 | 8,457 | 8,654 | 9,332 | 9,811 | 9,040 | 9,699 | 9,368 | 10,284 | 9,906 | 11,237 |
| Revenue growth (%) | - | ||||||||||||||
| Gross profit | - | - | - | 4,525 | 4,010 | 4,120 | 4,003 | 4,355 | 4,498 | 4,454 | 4,817 | 4,630 | 5,152 | 4,928 | 5,243 |
| Gross margin (%) | - | - | - | ||||||||||||
| Operating margin (%) | - | - | - | ||||||||||||
| Operating expenses | - | - | - | 2,237 | 2,369 | 2,701 | 2,511 | 2,837 | 3,241 | 2,847 | 2,955 | 2,981 | 3,312 | 3,628 | 3,574 |
| Operating income | - | - | - | 2,288 | 1,641 | 1,419 | 1,492 | 1,518 | 1,258 | 1,608 | 1,862 | 1,649 | 1,840 | 1,300 | 1,668 |
| Income before tax | 1,795 | 2,013 | 2,335 | 2,250 | 1,646 | 1,396 | 1,491 | 1,535 | 1,270 | 1,630 | 1,851 | 1,668 | 1,871 | 1,304 | 1,718 |
| Pretax margin (%) | 23.3 | 24.7 | 26.1 | 24.6 | 18.2 | 16.5 | 17.2 | 16.5 | 12.9 | 18 | 19.1 | 17.8 | 18.2 | 13.2 | 15.3 |
| Provision for income taxes | - | - | - | 821 | 606 | 149 | 362 | 451 | 339 | 496 | 570 | 515 | 512 | 315 | 454 |
| Effective tax rate (%) | - | - | - | ||||||||||||
| Net income | 1,031 | 1,276 | 1,454 | 1,429 | 1,197 | 458 | 1,309 | 1,098 | 1,000 | 1,153 | 1,281 | 1,151 | 1,348 | 1,005 | 1,071 |
| Earnings per share | 35,300.34 | 145.69 | 166.01 | 163.14 | 136.78 | 53.21 | 152.04 | 128.13 | 117.84 | 135.78 | 150.85 | 136.35 | 172.95 | 145.08 | 155.28 |
| Dividend per share | - | - | - | - | - | - | - | - | 49 | 51 | 60 | 60 | 68 | 68 | 129 |